US Stock MarketDetailed Quotes

TOVX Theriva Biologics

Watchlist

1.2806
+0.0006+0.05%

Trading Nov 22 12:39 ET

3.56MMarket Cap-39P/E (TTM)

Theriva Biologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Theriva Biologics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 0.000	--
--	2024/Q3	23.180K / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--
Mar 25, 2024	2023/Q4	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 0.000--

--2024/Q323.180K / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Mar 25, 20242023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Theriva Biologics Earnings Reports

Theriva Biologics | 10-Q: Q3 2024 Earnings Report

Nov 12 11:32 ET

Theriva Biologics | 8-K: Theriva™ Biologics Reports Third Quarter 2024 Operational Highlights and Financial Results

Nov 12 09:42 ET

Theriva Biologics | 10-Q: Q2 2024 Earnings Report

Aug 13 08:22 ET

Theriva Biologics | 8-K: Theriva™ Biologics Reports Second Quarter 2024 Operational Highlights and Financial Results

Aug 13 08:07 ET

Analyst Rating

Updated: Nov 13, 2024

Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall